TD Cowen raises Gilead Sciences stock price target on revenue beat
Covered in this story
What has happened since
- Gilead Sciences is down 1.5% since this was published, 15 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
TD Cowen’s $175 target on $GILD is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
TD Cowen’s track record →Analyst targets on Gilead Sciences
- Jefferies: at $156 · target $185 by Oct 2027 · Buy via Investing.com
- Bank of America: at $157 · target $172 by Oct 2027 · Buy via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $GILD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Gilead Sciences →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.